L1 retrotransposition in neurons is modulated by MeCP2

Area of Science:

• Genomics
• Neuroscience
• Molecular Biology

Background:

• Long interspersed nuclear elements-1 (LINE-1 or L1s) are abundant retrotransposons comprising ~20% of mammalian genomes.
• Active L1 retrotransposons influence genome integrity through insertions, deletions, and gene expression modulation.
• Previous work demonstrated L1 mobilization in rodent and human neuronal progenitor cells, with significant insertions in adult brain tissue.

Purpose of the Study:

• To investigate the role of methyl-CpG-binding protein 2 (MeCP2) in regulating neuronal L1 transcription and retrotransposition.
• To determine if MeCP2 mutations associated with neurodevelopmental disorders affect L1 retrotransposition frequency.
• To elucidate molecular mechanisms controlling L1 expression in the brain.

Main Methods:

• Utilized rodent models to study L1 retrotransposition in the absence of MeCP2.
• Employed human induced pluripotent stem cells (iPSCs) and tissue samples from patients with Rett syndrome (RTT).
• Analyzed L1 neuronal transcription and retrotransposition rates in relation to MeCP2 levels and mutations.

Main Results:

• L1 neuronal transcription and retrotransposition were significantly increased in rodents lacking MeCP2.
• Human iPSCs and tissues from RTT patients showed increased susceptibility to L1 retrotransposition.
• Demonstrated tissue-specific control of L1 retrotransposition influenced by disease-related genetic mutations.

Conclusions:

• MeCP2 plays a crucial role in suppressing L1 retrotransposition in neuronal cells.
• Mutations in MeCP2, as seen in RTT, can lead to heightened L1 retrotransposition, potentially contributing to neurological disorders.
• Findings highlight L1 retrotransposition as a factor in neurological disease complexity.